News from matrixx initiatives, inc

Feb 05, 2013, 09:00 ET

Matrixx Initiatives Withdraws Acquisition Offer for ProPhase Labs

Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has withdrawn the $1.60...

Dec 18, 2012, 15:05 ET
Zicam(R) Extreme Congestion Relief Lot 2J23 Expiration 09/15.  (PRNewsFoto/Matrixx Initiatives)

Matrixx Initiatives Issues Nationwide Voluntary Recall of One Lot of Zicam® Extreme Congestion Relief Due to Contamination With Burkholderia Cepacia

 Matrixx Initiatives is voluntarily recalling 1 lot of Zicam® Extreme Congestion Relief nasal gel.  The company is taking this step...

Oct 09, 2012, 07:05 ET

Matrixx Initiatives Files Presentation Regarding Its Offer To Acquire ProPhase Labs

 Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, today announced that it has filed a...

Oct 09, 2012, 07:02 ET

Matrixx Initiatives Revises All-cash Acquisition Offer For ProPhase Labs

 Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has increased its...

Feb 01, 2012, 13:24 ET
Matrixx Initiatives logo.  (PRNewsFoto/Matrixx Initiatives, Inc.)

Zicam® Maker, Matrixx Initiatives, Names Personal Care Products Pioneer M'lou Arnett as CEO

 Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, is proud to announce the appointment...

Sep 30, 2011, 17:02 ET

Matrixx Initiatives Announces Hearing Date for Schneider v. Hemelt, et al. Case

Matrixx Initiatives, Inc. today announced that the Superior Court of the State of Arizona in and for the County of Maricopa entered an order...

Jan 24, 2011, 07:00 ET

Matrixx Initiatives, Inc. Announces End of 'Go-Shop' Period

Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company"), an over-the-counter healthcare company that develops and markets Zicam®...

Jan 21, 2011, 07:00 ET

Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation

Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company"), an over-the-counter healthcare company that develops and markets Zicam®...

Jan 20, 2011, 16:10 ET

Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share

Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced...

Dec 29, 2010, 18:16 ET

Matrixx Initiatives, Inc. and H.I.G. Capital Announce Early Termination of HSR Waiting Period

Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company") and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm,...

Dec 22, 2010, 13:21 ET

Affiliates of H.I.G. Capital Launch $8.00 Per Share Cash Tender Offer for All Outstanding Shares of Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company") and H.I.G. Capital, LLC, a leading global private investment firm, today...

Dec 14, 2010, 08:10 ET

Matrixx Initiatives, Inc. to Be Acquired by H.I.G.

Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company") today announced that it has entered into a definitive merger agreement to be...

Dec 14, 2010, 08:00 ET

Matrixx Initiatives, Inc. Enters Settlement Agreement to Resolve Nationwide Personal Injury Litigation

Matrixx Initiatives, Inc. (Nasdaq: MTXX) and Lead Plaintiffs' Counsel in the Federal Multi-District Litigation in the District of Arizona and the...

Nov 16, 2010, 09:00 ET

Zicam and Dr. Andrea Pennington Team Up for Consumer Education Campaign

Matrixx Initiatives, Inc., makers of Zicam, today announced a partnership with noted health expert Dr. Andrea Pennington to help educate consumers...

Oct 25, 2010, 16:05 ET

Matrixx Initiatives, Inc. Reports Fiscal 2011 Second Quarter Net Sales of $21.3 Million and Net Income of $5.3 Million, or $0.57 Per Share

Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced...

Oct 19, 2010, 17:16 ET

Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results

Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2011 second...

Oct 19, 2010, 08:00 ET

Survey Reveals Majority of Americans Hold onto Myths About What Causes Colds and How to Treat Them

A new national survey of U.S. adults has found the majority of Americans are misinformed about what causes the common cold, and how and when they...

Aug 03, 2010, 16:10 ET

Matrixx Initiatives, Inc. Reports Fiscal 2011 First Quarter Results

Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced...

Jul 28, 2010, 18:49 ET

Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results

Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2011 first...

May 19, 2010, 12:59 ET

Matrixx Initiatives, Inc. Names William J. Barba Vice President of Finance and Accounting, and Treasurer

Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge